Loading…

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2018-07, Vol.103 (7), p.e304-e306
Main Authors: Feugier, Pierre, Aurran, Thérèse, Mahé, Béatrice, Letestu, Remi, Nguyen-Khac, Florence, Cazin, Bruno, Tournilhac, Olivier, Maisonneuve, Hervé, Casasnovas, Olivier, Delmer, Alain, Leblond, Véronique, Royer, Bruno, Corront, Bernadette, Chevret, Sylvie, Delépine, Roselyne, Vaudaux, Sandrine, Van Den Neste, Eric, Béné, Marie-Christine, Cymbalista, Florence, Ross-Weil, Damien, Leprêtre, Stéphane
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c508t-52dedb88af7d5d4e445a2033841693b7f0dd8b0829bb6bdcba87858856adb08a3
cites
container_end_page e306
container_issue 7
container_start_page e304
container_title Haematologica (Roma)
container_volume 103
creator Feugier, Pierre
Aurran, Thérèse
Mahé, Béatrice
Letestu, Remi
Nguyen-Khac, Florence
Cazin, Bruno
Tournilhac, Olivier
Maisonneuve, Hervé
Casasnovas, Olivier
Delmer, Alain
Leblond, Véronique
Royer, Bruno
Corront, Bernadette
Chevret, Sylvie
Delépine, Roselyne
Vaudaux, Sandrine
Van Den Neste, Eric
Béné, Marie-Christine
Cymbalista, Florence
Ross-Weil, Damien
Leprêtre, Stéphane
description
doi_str_mv 10.3324/haematol.2017.183350
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fb162868f6f44144bebd9ca08b0b89bf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fb162868f6f44144bebd9ca08b0b89bf</doaj_id><sourcerecordid>2014948804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-52dedb88af7d5d4e445a2033841693b7f0dd8b0829bb6bdcba87858856adb08a3</originalsourceid><addsrcrecordid>eNpdks9u1DAQxiMEoqXwBgj5CIcsjuMkzgWpWrW0UhAc4GyN48nGxYmD42xZHpJnwkvainLxn_F8v_HYX5K8zugmzxl_3wMOEJzdMJpVm0zkeUGfJKdZUbNUVCx7mpzSvKZpSStxkryY5xtKGa3r6nlywuqCFzkXp8nvxo27NKAfSOesdbdkmYjrSOiRbJuGUVpdfvpCgjdgCe7BLhDMuCOdXTR4UGZEAqMm7aG1burdPPUwGI3EjKR1QzyP-W4ktyb0BOOAnngTlp9mAEWcJ2BxCMuv5biNmsnj3rhltgeyjMEjBNRkigwcw7xS2t670bTEHoZYsD2E4xqX7zgYeJk868DO-OpuPku-XV583V6lzeeP19vzJm0LKkJaMI1aCQFdpQvNkfMCGM1zwbOyzlXVUa2FooLVSpVKtwpEJQohihJ0DEN-llyvXO3gRk4-duMP0oGRfwPO7yT4eDGLslNZyUQpurLjPONcodJ1CzTylahVF1kfVta0qAF1Gzv1YB9BH5-Mppc7t5cljf9Y5BHwbgX0_8muzht5jNFMlJQzts9i7tu7Yt79WHAOcjBzi9bCiPHZZTQTr7kQlMdUvqa23s2zx-6BnVF5tKC8t-BRVcnVglH25t92HkT3nsv_ANOy4KA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014948804</pqid></control><display><type>article</type><title>Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia</title><source>Open Access: PubMed Central</source><source>Freely Accessible Science Journals - check A-Z of ejournals</source><creator>Feugier, Pierre ; Aurran, Thérèse ; Mahé, Béatrice ; Letestu, Remi ; Nguyen-Khac, Florence ; Cazin, Bruno ; Tournilhac, Olivier ; Maisonneuve, Hervé ; Casasnovas, Olivier ; Delmer, Alain ; Leblond, Véronique ; Royer, Bruno ; Corront, Bernadette ; Chevret, Sylvie ; Delépine, Roselyne ; Vaudaux, Sandrine ; Van Den Neste, Eric ; Béné, Marie-Christine ; Cymbalista, Florence ; Ross-Weil, Damien ; Leprêtre, Stéphane</creator><creatorcontrib>Feugier, Pierre ; Aurran, Thérèse ; Mahé, Béatrice ; Letestu, Remi ; Nguyen-Khac, Florence ; Cazin, Bruno ; Tournilhac, Olivier ; Maisonneuve, Hervé ; Casasnovas, Olivier ; Delmer, Alain ; Leblond, Véronique ; Royer, Bruno ; Corront, Bernadette ; Chevret, Sylvie ; Delépine, Roselyne ; Vaudaux, Sandrine ; Van Den Neste, Eric ; Béné, Marie-Christine ; Cymbalista, Florence ; Ross-Weil, Damien ; Leprêtre, Stéphane</creatorcontrib><identifier>ISSN: 0390-6078</identifier><identifier>EISSN: 1592-8721</identifier><identifier>DOI: 10.3324/haematol.2017.183350</identifier><identifier>PMID: 29545348</identifier><language>eng</language><publisher>Italy: Ferrata Storti Foundation</publisher><subject>Hematology ; Human health and pathology ; Life Sciences ; Online Only</subject><ispartof>Haematologica (Roma), 2018-07, Vol.103 (7), p.e304-e306</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright© 2018 Ferrata Storti Foundation 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-52dedb88af7d5d4e445a2033841693b7f0dd8b0829bb6bdcba87858856adb08a3</citedby><orcidid>0000-0002-7767-755X ; 0000-0002-9438-621X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029553/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029553/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29545348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://uca.hal.science/hal-01860422$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Feugier, Pierre</creatorcontrib><creatorcontrib>Aurran, Thérèse</creatorcontrib><creatorcontrib>Mahé, Béatrice</creatorcontrib><creatorcontrib>Letestu, Remi</creatorcontrib><creatorcontrib>Nguyen-Khac, Florence</creatorcontrib><creatorcontrib>Cazin, Bruno</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Maisonneuve, Hervé</creatorcontrib><creatorcontrib>Casasnovas, Olivier</creatorcontrib><creatorcontrib>Delmer, Alain</creatorcontrib><creatorcontrib>Leblond, Véronique</creatorcontrib><creatorcontrib>Royer, Bruno</creatorcontrib><creatorcontrib>Corront, Bernadette</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><creatorcontrib>Delépine, Roselyne</creatorcontrib><creatorcontrib>Vaudaux, Sandrine</creatorcontrib><creatorcontrib>Van Den Neste, Eric</creatorcontrib><creatorcontrib>Béné, Marie-Christine</creatorcontrib><creatorcontrib>Cymbalista, Florence</creatorcontrib><creatorcontrib>Ross-Weil, Damien</creatorcontrib><creatorcontrib>Leprêtre, Stéphane</creatorcontrib><title>Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia</title><title>Haematologica (Roma)</title><addtitle>Haematologica</addtitle><subject>Hematology</subject><subject>Human health and pathology</subject><subject>Life Sciences</subject><subject>Online Only</subject><issn>0390-6078</issn><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdks9u1DAQxiMEoqXwBgj5CIcsjuMkzgWpWrW0UhAc4GyN48nGxYmD42xZHpJnwkvainLxn_F8v_HYX5K8zugmzxl_3wMOEJzdMJpVm0zkeUGfJKdZUbNUVCx7mpzSvKZpSStxkryY5xtKGa3r6nlywuqCFzkXp8nvxo27NKAfSOesdbdkmYjrSOiRbJuGUVpdfvpCgjdgCe7BLhDMuCOdXTR4UGZEAqMm7aG1burdPPUwGI3EjKR1QzyP-W4ktyb0BOOAnngTlp9mAEWcJ2BxCMuv5biNmsnj3rhltgeyjMEjBNRkigwcw7xS2t670bTEHoZYsD2E4xqX7zgYeJk868DO-OpuPku-XV583V6lzeeP19vzJm0LKkJaMI1aCQFdpQvNkfMCGM1zwbOyzlXVUa2FooLVSpVKtwpEJQohihJ0DEN-llyvXO3gRk4-duMP0oGRfwPO7yT4eDGLslNZyUQpurLjPONcodJ1CzTylahVF1kfVta0qAF1Gzv1YB9BH5-Mppc7t5cljf9Y5BHwbgX0_8muzht5jNFMlJQzts9i7tu7Yt79WHAOcjBzi9bCiPHZZTQTr7kQlMdUvqa23s2zx-6BnVF5tKC8t-BRVcnVglH25t92HkT3nsv_ANOy4KA</recordid><startdate>20180701</startdate><enddate>20180701</enddate><creator>Feugier, Pierre</creator><creator>Aurran, Thérèse</creator><creator>Mahé, Béatrice</creator><creator>Letestu, Remi</creator><creator>Nguyen-Khac, Florence</creator><creator>Cazin, Bruno</creator><creator>Tournilhac, Olivier</creator><creator>Maisonneuve, Hervé</creator><creator>Casasnovas, Olivier</creator><creator>Delmer, Alain</creator><creator>Leblond, Véronique</creator><creator>Royer, Bruno</creator><creator>Corront, Bernadette</creator><creator>Chevret, Sylvie</creator><creator>Delépine, Roselyne</creator><creator>Vaudaux, Sandrine</creator><creator>Van Den Neste, Eric</creator><creator>Béné, Marie-Christine</creator><creator>Cymbalista, Florence</creator><creator>Ross-Weil, Damien</creator><creator>Leprêtre, Stéphane</creator><general>Ferrata Storti Foundation</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7767-755X</orcidid><orcidid>https://orcid.org/0000-0002-9438-621X</orcidid></search><sort><creationdate>20180701</creationdate><title>Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia</title><author>Feugier, Pierre ; Aurran, Thérèse ; Mahé, Béatrice ; Letestu, Remi ; Nguyen-Khac, Florence ; Cazin, Bruno ; Tournilhac, Olivier ; Maisonneuve, Hervé ; Casasnovas, Olivier ; Delmer, Alain ; Leblond, Véronique ; Royer, Bruno ; Corront, Bernadette ; Chevret, Sylvie ; Delépine, Roselyne ; Vaudaux, Sandrine ; Van Den Neste, Eric ; Béné, Marie-Christine ; Cymbalista, Florence ; Ross-Weil, Damien ; Leprêtre, Stéphane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-52dedb88af7d5d4e445a2033841693b7f0dd8b0829bb6bdcba87858856adb08a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Hematology</topic><topic>Human health and pathology</topic><topic>Life Sciences</topic><topic>Online Only</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feugier, Pierre</creatorcontrib><creatorcontrib>Aurran, Thérèse</creatorcontrib><creatorcontrib>Mahé, Béatrice</creatorcontrib><creatorcontrib>Letestu, Remi</creatorcontrib><creatorcontrib>Nguyen-Khac, Florence</creatorcontrib><creatorcontrib>Cazin, Bruno</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Maisonneuve, Hervé</creatorcontrib><creatorcontrib>Casasnovas, Olivier</creatorcontrib><creatorcontrib>Delmer, Alain</creatorcontrib><creatorcontrib>Leblond, Véronique</creatorcontrib><creatorcontrib>Royer, Bruno</creatorcontrib><creatorcontrib>Corront, Bernadette</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><creatorcontrib>Delépine, Roselyne</creatorcontrib><creatorcontrib>Vaudaux, Sandrine</creatorcontrib><creatorcontrib>Van Den Neste, Eric</creatorcontrib><creatorcontrib>Béné, Marie-Christine</creatorcontrib><creatorcontrib>Cymbalista, Florence</creatorcontrib><creatorcontrib>Ross-Weil, Damien</creatorcontrib><creatorcontrib>Leprêtre, Stéphane</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feugier, Pierre</au><au>Aurran, Thérèse</au><au>Mahé, Béatrice</au><au>Letestu, Remi</au><au>Nguyen-Khac, Florence</au><au>Cazin, Bruno</au><au>Tournilhac, Olivier</au><au>Maisonneuve, Hervé</au><au>Casasnovas, Olivier</au><au>Delmer, Alain</au><au>Leblond, Véronique</au><au>Royer, Bruno</au><au>Corront, Bernadette</au><au>Chevret, Sylvie</au><au>Delépine, Roselyne</au><au>Vaudaux, Sandrine</au><au>Van Den Neste, Eric</au><au>Béné, Marie-Christine</au><au>Cymbalista, Florence</au><au>Ross-Weil, Damien</au><au>Leprêtre, Stéphane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia</atitle><jtitle>Haematologica (Roma)</jtitle><addtitle>Haematologica</addtitle><date>2018-07-01</date><risdate>2018</risdate><volume>103</volume><issue>7</issue><spage>e304</spage><epage>e306</epage><pages>e304-e306</pages><issn>0390-6078</issn><eissn>1592-8721</eissn><cop>Italy</cop><pub>Ferrata Storti Foundation</pub><pmid>29545348</pmid><doi>10.3324/haematol.2017.183350</doi><orcidid>https://orcid.org/0000-0002-7767-755X</orcidid><orcidid>https://orcid.org/0000-0002-9438-621X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0390-6078
ispartof Haematologica (Roma), 2018-07, Vol.103 (7), p.e304-e306
issn 0390-6078
1592-8721
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fb162868f6f44144bebd9ca08b0b89bf
source Open Access: PubMed Central; Freely Accessible Science Journals - check A-Z of ejournals
subjects Hematology
Human health and pathology
Life Sciences
Online Only
title Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A02%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow%20up%20of%20the%20CLL2007FMP%20trial%20evaluating%20fludarabine%20and%20cyclophosphamide%20in%20combination%20with%20either%20rituximab%20or%20alemtuzumab%20in%20previously%20untreated%20patients%20with%20chronic%20lymphocytic%20leukemia&rft.jtitle=Haematologica%20(Roma)&rft.au=Feugier,%20Pierre&rft.date=2018-07-01&rft.volume=103&rft.issue=7&rft.spage=e304&rft.epage=e306&rft.pages=e304-e306&rft.issn=0390-6078&rft.eissn=1592-8721&rft_id=info:doi/10.3324/haematol.2017.183350&rft_dat=%3Cproquest_doaj_%3E2014948804%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-52dedb88af7d5d4e445a2033841693b7f0dd8b0829bb6bdcba87858856adb08a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2014948804&rft_id=info:pmid/29545348&rfr_iscdi=true